- Home
- EMKR vs OGEN Comparison
EMKR vs OGEN Comparison
Compare EMKR & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMKR
- OGEN
- Stock Information
- Founded
- EMKR 1984
- OGEN 1996
- Country
- EMKR United States
- OGEN United States
- Employees
- EMKR N/A
- OGEN N/A
- Industry
- EMKR Semiconductors
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- EMKR Technology
- OGEN Health Care
- Exchange
- EMKR Nasdaq
- OGEN Nasdaq
- Market Cap
- EMKR 9.5M
- OGEN 4.5M
- IPO Year
- EMKR 1997
- OGEN N/A
- Fundamental
- Price
- EMKR $2.33
- OGEN $0.34
- Analyst Decision
- EMKR Buy
- OGEN
- Analyst Count
- EMKR 2
- OGEN 0
- Target Price
- EMKR $3.00
- OGEN N/A
- AVG Volume (30 Days)
- EMKR 2.0M
- OGEN 392.1K
- Earning Date
- EMKR 12-10-2024
- OGEN 11-07-2024
- Dividend Yield
- EMKR N/A
- OGEN N/A
- EPS Growth
- EMKR N/A
- OGEN N/A
- EPS
- EMKR N/A
- OGEN N/A
- Revenue
- EMKR $90,961,000.00
- OGEN $7,466.00
- Revenue This Year
- EMKR N/A
- OGEN N/A
- Revenue Next Year
- EMKR $7.07
- OGEN N/A
- P/E Ratio
- EMKR N/A
- OGEN N/A
- Revenue Growth
- EMKR 413.79
- OGEN N/A
- 52 Week Low
- EMKR $0.78
- OGEN $0.29
- 52 Week High
- EMKR $7.20
- OGEN $7.74
- Technical
- Relative Strength Index (RSI)
- EMKR 67.47
- OGEN 36.96
- Support Level
- EMKR $2.07
- OGEN $0.29
- Resistance Level
- EMKR $2.54
- OGEN $0.35
- Average True Range (ATR)
- EMKR 0.16
- OGEN 0.04
- MACD
- EMKR -0.02
- OGEN 0.02
- Stochastic Oscillator
- EMKR 55.32
- OGEN 31.19
About EMKR EMCORE Corporation
EMCORE Corp is a provider of sensors and navigation systems for the aerospace and defense market. The company operates in one reporting segment, Inertial Navigation, whose product technology categories include: (a) FOG, (b) QMEMS, (c) RLG, in each case which serve the aerospace and defense market. The company operates geographically in United States and Canada, which is the key revenue generator; Asia; Europe; and Other.
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.